Harnessing the Effect of an Open-Label Placebo on Fatigue in Cancer Survivors

Stopped early · Not applicable · Has a placebo group

Conditions studied: Fatigue in Cancer Survivors

In brief

This research study is evaluating the usefulness of a placebo (a tablet with no active ingredients) on fatigue in cancer survivors.

Key facts

Study ID

NCT02452710

Run by

Dana-Farber Cancer Institute

People needed

40

Starts

2015-08-01

Expected to finish

2017-02-01

Last updated by the study team

2018-12-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Cancer survivor, with no evidence of active disease
• ≥18 years of age
• ≥6 months and <10 years post active treatment
• Reports being bothered by fatigue in the past month and has a score of <43 on FACIT-F.
• Able to read and write in English

You may not qualify if…

• Being evaluated or likely to be evaluated for a medical cause of fatigue (e.g., anemia, hypothyroidism) during the study. (per provider report)
• Have indications of sleep apnea as assessed by Epworth Sleepiness scale score ≥10.
• Are receiving, or are likely to receive another intervention for the treatment of fatigue during the study period. (per provider report)

Where it is running

• Dana Farber Cancer Institute — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.